期刊文献+

尿液中膀胱癌肿瘤标记物的研究进展 被引量:6

下载PDF
导出
摘要 目前膀胱癌诊断及随访主要依靠尿细胞学检查与膀胱镜检相结合的手段,现有方法不仅费用较昂贵,同时为患者带来较大的痛苦。尿液作为无创标本,可提供蛋白质、RNA及DNA来源,是膀胱癌理想的肿瘤标记物。近年来,有较多研究关注于尿液中膀胱癌肿瘤标记物的应用。本文主要概述了现有的尿液中膀胱癌肿瘤标志物的研究进展,并讨论其存在的不足及研究前景。
作者 于浩 林天歆
出处 《岭南现代临床外科》 2012年第2期159-160,F0003,共3页 Lingnan Modern Clinics in Surgery
基金 国家自然科学基金面上项目(81071688)
  • 相关文献

参考文献21

  • 1吴阶平.吴阶平泌尿外科学[M]济南:山东科学技术出版社,2003919-942.
  • 2Jemal A,Siegel R,Xu J. Cancer statistics,2010[J].CA:A Cancer Journal for Clinicians,2010,(05):277-300.doi:10.3322/caac.20073.
  • 3Jacobs BL,Lee CT,Montie JE. Bladder cancer in2010:how far have we come[J].CA:A Cancer Journal for Clinicians,2010,(04):244-272.doi:10.3322/caac.20077.
  • 4Ian Proctor,Kai Stoeber,Gareth H Williams. Biomarkers in bladder cancer[J].Histopathology,2010,(01):1-13.
  • 5Sharma S,Zippe CD,Pandrangi L. Exclusioncriteria enhance the specificity and positive predictivevalue of NMP22 and BTA stat[J].The Journal of Urology,1999,(01):53-57.
  • 6van Rhijn BW,van der PoelHG,van der Kwast TH. Urine markers for bladder cancer surveillance:asystematic review[J].European Urology,2005,(06):736-748.
  • 7Grossman HB,Soloway M,Messing E. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay[J].Journal of the American Medical Association,2006,(03):299-305.
  • 8Bergeron A,LaRue H,Fradet Y. Identification of asuperficial bladder tumor-associated glycoform of thecarcinoembryonic antigen by monoclonal antibody19A211[J].Cancer Research,1996,(04):908-915.
  • 9Budman LI,Kassouf W,Steinberg JR. Biomarkers fordetection and surveillance of bladder cancer[J].CanUrol Assoc J,2008,(03):212-221.
  • 10van Oers JM,LurkinI,van Exsel AJ. A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine[J].Clinical Cancer Research,2005,(21):7743-7748.

同被引文献68

  • 1张锁英,李长生,黄龙学,秦士杰,卜燕燕,孙迷离.尿CEA检测对膀胱癌诊断的临床意义[J].实用癌症杂志,1993,8(3):132-133. 被引量:1
  • 2徐卓群,徐汇义.尿癌胚抗原检测对膀胱癌的诊断价值[J].标记免疫分析与临床,1995,2(1):48-49. 被引量:1
  • 3惠军锋,刘玉芹.液基薄层细胞学筛查宫颈癌的临床研究[J].陕西医学杂志,2007,36(10):1340-1341. 被引量:4
  • 4陈丽宏,刘晓琴,杨春荣,姚蕾.液基细胞学联合高危型HPV检测在宫颈疾病诊断中的应用[J].陕西医学杂志,2007,36(10):1377-1379. 被引量:8
  • 5Jemal A,Clegg LX,Ward E,et al. Annual report to the nation on the status of cancer, 1975 -2001, with a special feature regarding survival[J].Cancer, 2004,101 (1) : 23-27.
  • 6Pfister C,Chautard D,Devonec M,et al. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study[J]. J Urol, 2003,169 ( 3 ) : 921-924.
  • 7El-Assal ON, Yamanoi A, Ono T, et al. The clinicopathological significance of heparanase and basic fibroblast growth factor ex pressions in hepatocellular carcinoma[J]. Clin Cancer Res, 2001,7 (5) : 1299-1305.
  • 8Stavropoulos NE,Filliadis I,loaehim E,et ah CD44 stanclara Iorm expression as a predictor of progression in high risk superficial bladder tumors[J].Jnt Urol Nephrol,2001,33(3) :479-483.
  • 9Ishida T. Immunohistochemical expression of the CD44 variant 6 in coloreetal adenocarcinoma[J]. Surg Today, 2000,80 (1) : 28-32.
  • 10Li CZ, Liu B, Wen ZQ, et al. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian Cancer cells in vitro and in vivo[J]. Folia Biol (Krakow), 2008,54(6) :180- 186.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部